ZIVO (Zivo Bioscience) EBITDA Margin %: -1,545.45% (As of Sep. 2025)

What is Zivo Bioscience EBITDA Margin %?

Zivo Bioscience ZIVO -27.08% 14 EBITDA Margin % is -1,545.45% as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 945 Biotechnology companies, Zivo Bioscience ranks worse than 89.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zivo Bioscience's EBITDA for the three months ended in Sep. 2025 was $-1.02 Mil. Zivo Bioscience's Revenue for the three months ended in Sep. 2025 was $0.07 Mil. Therefore, Zivo Bioscience's EBITDA margin for the quarter that ended in Sep. 2025 was -1,545.45%.

Zivo Bioscience (OTCPK:ZIVO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Zivo Bioscience EBITDA Margin % Related Terms

Zivo Bioscience EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience EBITDA Margin % Chart

Zivo Bioscience Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

Get a 7-Day Free Trial

-42,780.00

0.00

-25,939.29

-8,510.83

Zivo Bioscience Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25
EBITDA Margin %	Get a 7-Day Free Trial															-7,062.50	-1,773.33	0.00	-3,081.13	-1,545.45

ZIVO vs INAB, LPCN, CTXR: EBITDA Margin % Comparison

For the Biotechnology subindustry, Zivo Bioscience's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zivo Bioscience EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zivo Bioscience's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Zivo Bioscience's EBITDA Margin % falls into.

Save Embed

14GF Score

Zivo Bioscience Inc ZIVO

EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zivo Bioscience EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Zivo Bioscience's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-13.362	/	0.157
	=	-8,510.83 %

Zivo Bioscience's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2025 )	/	Revenue (Q: Sep. 2025 )
	=	-1.02	/	0.066
	=	-1,545.45 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -1,545.45% mean?

Zivo Bioscience (ZIVO) has a EBITDA Margin % of -1,545.45% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zivo Bioscience and its competitors. According to the industry distribution chart, Zivo Bioscience ranks #842 out of 945 companies in the Biotechnology industry, placing it in the top 89.1%.

Is Zivo Bioscience's EBITDA Margin % too high?

Zivo Bioscience's current EBITDA Margin % is -1,545.45%. Based on the distribution chart, Zivo Bioscience ranks #842 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.

How does Zivo Bioscience's EBITDA Margin % compare to INAB and LPCN?

According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #842 out of 945 companies for EBITDA Margin %. This places Zivo Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Biotechnology company?

A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current EBITDA Margin % is -1,545.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zivo Bioscience stock overvalued right now?

Zivo Bioscience (ZIVO) has a current EBITDA Margin % of -1,545.45%. The current EBITDA Margin % is -1,545.45%. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current EBITDA Margin % is -1,545.45% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Industry Healthcare Biotechnology

Comparable Companies INAB LPCN CTXR AKTX PASG NCEL ANEB GTBP AEON HIND VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084

Website https://www.zivobioscience.com

Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.

14GF Score

Get the complete analysis for ZIVO

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15

Price

View ZIVO Analysis

See EBITDA Margin % data for all stocks →